Compile Data Set for Download or QSAR
Report error Found 219 Enz. Inhib. hit(s) with all data for entry = 50021106
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552729(WO2022103411, Compound 52 | (2S,4R)-l-((S)-2-(4-cy...)
Affinity DataKd: <2.5nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552729(WO2022103411, Compound 52 | (2S,4R)-l-((S)-2-(4-cy...)
Affinity DataKd: <2.5nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637018(CHEMBL5568085)
Affinity DataKd: <2.5nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637018(CHEMBL5568085)
Affinity DataKd:  2.80nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552702((2S,4R)-l-((S)-2-(4-cyclopropyl-lH-l,2,3-triazol-l...)
Affinity DataKd:  3.30nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552702((2S,4R)-l-((S)-2-(4-cyclopropyl-lH-l,2,3-triazol-l...)
Affinity DataKd:  3.90nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552686((2S,4R)-l-((S)-2-(4-cyclopropyl-lH-l,2,3-triazol-l...)
Affinity DataKd:  6.30nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552686((2S,4R)-l-((S)-2-(4-cyclopropyl-lH-l,2,3-triazol-l...)
Affinity DataKd:  6.5nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637013(CHEMBL5561098)
Affinity DataKd:  59nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637015(CHEMBL5557410)
Affinity DataKd:  63nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637017(CHEMBL5523602)
Affinity DataKd:  67nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637013(CHEMBL5561098)
Affinity DataKd:  69nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637009(CHEMBL5557627)
Affinity DataKd:  71nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637014(CHEMBL5565598)
Affinity DataKd:  74nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637017(CHEMBL5523602)
Affinity DataKd:  83nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637015(CHEMBL5557410)
Affinity DataKd:  84nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552696(WO2022103411, Example S11)
Affinity DataKd:  85nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637009(CHEMBL5557627)
Affinity DataKd:  85nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637014(CHEMBL5565598)
Affinity DataKd:  87nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637008(CHEMBL5567564)
Affinity DataKd:  95nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637008(CHEMBL5567564)
Affinity DataKd:  99nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637012(CHEMBL5559950)
Affinity DataKd:  99nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637016(CHEMBL5556367)
Affinity DataKd:  100nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637016(CHEMBL5556367)
Affinity DataKd:  110nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552695((2S,4R)-N-((R)-3-([l,l'-biphenyl]-4-yl)-l-amino-l-...)
Affinity DataKd:  110nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552696(WO2022103411, Example S11)
Affinity DataKd:  120nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50615684(CHEMBL4565531)
Affinity DataKd:  120nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637012(CHEMBL5559950)
Affinity DataKd:  130nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637000(CHEMBL5523400)
Affinity DataKd:  130nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552695((2S,4R)-N-((R)-3-([l,l'-biphenyl]-4-yl)-l-amino-l-...)
Affinity DataKd:  160nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637000(CHEMBL5523400)
Affinity DataKd:  160nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552714(WO2022103411, Compound 32 | (2S,4R)-N-((R)-3-([l,l...)
Affinity DataKd:  160nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552694((2S,4R)-N-((R)-3-([l,l'-biphenyl]-4-yl)-l-amino-l-...)
Affinity DataKd:  170nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50099062(CHEMBL3344081 | US10730870, Example 3 | US11512083...)
Affinity DataKd:  180nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50615684(CHEMBL4565531)
Affinity DataKd:  180nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50099062(CHEMBL3344081 | US10730870, Example 3 | US11512083...)
Affinity DataKd:  200nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552700(l-((S)-l-((2S,4R)-2-(((R)-3-([l,l'-biphenyl]-4-yl)...)
Affinity DataKd:  210nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50636924(CHEMBL5561983)
Affinity DataKd:  210nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552701(l-((S)-l-((2S,4R)-2-(((R)-3-([l,l'-biphenyl]-4-yl)...)
Affinity DataKd:  250nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552714(WO2022103411, Compound 32 | (2S,4R)-N-((R)-3-([l,l...)
Affinity DataKd:  260nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552694((2S,4R)-N-((R)-3-([l,l'-biphenyl]-4-yl)-l-amino-l-...)
Affinity DataKd:  260nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552699(l-((S)-l-((2S,4R)-2-(((R)-3-([l,l'-biphenyl]-4-yl)...)
Affinity DataKd:  310nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50636965(CHEMBL5560777)
Affinity DataKd:  410nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50636922(CHEMBL5565425)
Affinity DataKd:  500nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552729(WO2022103411, Compound 52 | (2S,4R)-l-((S)-2-(4-cy...)
Affinity DataKd:  540nMAssay Description:Binding affinity to Navi-tagged VHL (unknown origin) assessed as dissociation constant by SPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50636965(CHEMBL5560777)
Affinity DataKd:  680nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50637004(CHEMBL5563285)
Affinity DataKd:  1.00E+3nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50636961(CHEMBL5542362)
Affinity DataKd:  1.30E+3nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM552701(l-((S)-l-((2S,4R)-2-(((R)-3-([l,l'-biphenyl]-4-yl)...)
Affinity DataKd:  1.30E+3nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Human)
Genentech

Curated by ChEMBL
LigandPNGBDBM50636957(CHEMBL5558694)
Affinity DataKd:  1.40E+3nMAssay Description:Binding affinity to VHL (unknown origin)-NanoLuc fusion protein expressed in HEK293 cells assessed as apparent dissociation constant incubated for 30...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
Displayed 1 to 50 (of 219 total ) | Next | Last >>
Jump to: